Global phase III with 605 patients from the US and eight European countries demonstrates therapeutic equivalence and safety between Stelara and DMB-3115 Aims to submit marketing authorization
PALM BEACH, Fla., Nov. 10, 2022 /PRNewswire/ FinancialNewsMedia.com News Commentary - The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market competition
/PRNewswire/ FinancialNewsMedia.com News Commentary - The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market.
- Dong-A building a foundation for expanding its biosimilar business through license-out and supply agreements to Türkiye, Brazil and Mexico - Creating a synergy effect with STgen Bio, an affiliated
NeuroBo Pharmaceuticals (NRBO) and Enters Collaboration to License and Develop Portfolio of Dong-A s Cardio-Metabolic Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.